• Latest Posts

Eterna acquires allogeneic immuno-oncology platform from Exacis 

First drug discovered through 3D bioprinted tissue disease model

Cabaletta Bio’s lupus drug cleared for trial

FDA fast track for Memo’s kidney transplant infection treatment

Astellas eyes ophthalmology field with $5.9B Iveric Bio takeover

Schizophrenia injection gets FDA approval

ADVERTISEMENT

Single-molecule valve breakthrough could lead to early disease diagnosis

Brenus Pharma reveals ‘groundbreaking’ preclinical results for colorectal cancer and solid tumor drug

Mezzion Pharma raises $40M for treatment option for heart surgery patients

Vitalli Bio formed to focus on immunological disorders

ADC firm Adcentrx Therapeutics aims for clinic after $38M boost

Australian biopharma Telix banks on AI with Dedicaid acquisition

ADVERTISEMENT